Exact Mass: 471.1627968000001
Exact Mass Matches: 471.1627968000001
Found 55 metabolites which its exact mass value is equals to given mass value 471.1627968000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
CAY10650
CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion[1][2].
Asp His Asn Ser
C17H25N7O9 (471.17136800000003)
Asp His Ser Asn
C17H25N7O9 (471.17136800000003)
Asp Asn His Ser
C17H25N7O9 (471.17136800000003)
Asp Asn Ser His
C17H25N7O9 (471.17136800000003)
Asp Ser His Asn
C17H25N7O9 (471.17136800000003)
Asp Ser Asn His
C17H25N7O9 (471.17136800000003)
His Asp Asn Ser
C17H25N7O9 (471.17136800000003)
His Asp Ser Asn
C17H25N7O9 (471.17136800000003)
His Asn Asp Ser
C17H25N7O9 (471.17136800000003)
His Asn Ser Asp
C17H25N7O9 (471.17136800000003)
His Ser Asp Asn
C17H25N7O9 (471.17136800000003)
His Ser Asn Asp
C17H25N7O9 (471.17136800000003)
Asn Asp His Ser
C17H25N7O9 (471.17136800000003)
Asn Asp Ser His
C17H25N7O9 (471.17136800000003)
Asn His Asp Ser
C17H25N7O9 (471.17136800000003)
Asn His Ser Asp
C17H25N7O9 (471.17136800000003)
Asn Ser Asp His
C17H25N7O9 (471.17136800000003)
Asn Ser His Asp
C17H25N7O9 (471.17136800000003)
Ser Asp His Asn
C17H25N7O9 (471.17136800000003)
Ser Asp Asn His
C17H25N7O9 (471.17136800000003)
Ser His Asp Asn
C17H25N7O9 (471.17136800000003)
Ser His Asn Asp
C17H25N7O9 (471.17136800000003)
Ser Asn Asp His
C17H25N7O9 (471.17136800000003)
Ser Asn His Asp
C17H25N7O9 (471.17136800000003)
Dorsomorphin 2HCl
Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).
Quinacrine dihydrochloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
N-[1-[4-(2-methoxyphenyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]benzenesulfonamide
C24H29N3O3S2 (471.16502440000005)
4-(2-Hydroxybenzylamino)-N-(3-(4-fluorophenoxy)phenyl)piperidine-1-sulfonamide
C24H26FN3O4S (471.1627968000001)
2-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-YL)ethyl]-4-(4-ethoxy-1,1-biphenyl-4-YL)-4-oxobutanoic acid
alpha-Neup5Ac-(2->6)-beta-D-Galp
alpha-Neup5Ac-(2->6)-D-Galp in which the anomeric configuration of the reducing-end D-galactose residue is beta.
alpha-Neu5Ac-(2->3)-D-Gal
An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position
1-[(4-fluorophenyl)methyl]-4-(3,4,5-trimethoxyphenyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
C25H26FNO7 (471.16932180000003)
alpha-Neup5Ac-(2->6)-D-Galp
An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 6-position
3-[2,4-dioxo-1-[(4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-quinazolinyl]-N-(2-furanylmethyl)propanamide
C25H21N5O5 (471.15426160000004)
3-O-{5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl}-alpha-D-galactopyranose
3-O-(5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranonosyl)-D-galactopyranose
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranose
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-alpha-D-galacto-hexopyranose
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-methyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H29N3O8S (471.16752740000004)
(2R,4S,5R,6R)-5-acetamido-2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
alpha-Neup5Ac-(2->3)-beta-D-Galp
An amino disaccharide consisting of beta-D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position
alpha-Neup5Ac-(2->3)-alpha-D-GalpNAc
An amino disaccharide comprised of an N-acetyl-alpha-neuraminyl residue linked (2->3) to N-acetyl-alpha-D-galactosamine
(15r,16r,17s,18r,20s)-2,15,16-trihydroxy-8-[(1r)-1-hydroxypropyl]-17-methoxy-6,18-dimethyl-19,21-dioxa-7-azapentacyclo[12.7.0.0³,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(14),2,4(9),5,7,11-hexaene-10,13-dione
n-{[(2r,3s,4r,5s)-5-(2,4-dihydroxypyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methyl}-2-{[1-hydroxy-2-(c-hydroxycarbonimidoylamino)ethylidene]amino}pentanediimidic acid
C17H25N7O9 (471.17136800000003)